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Abstract
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Age-related decreases in Quality of Life (QoL) are often compounded by comorbidities, including
cancer. This study aimed to examine QoL changes before and after a new cancer diagnosis using
data from the National Health and Aging Trend Study (NHATS), linked to Medicare claims (N =
136). There was a significant increase in the relative odds of fair/poor self-reported health and
needing help with Activities of Daily Living. There was also a marginal increase in depression, but
no change in anxiety or pain scores. Results underscore importance of considering pre-cancer QoL
when making treatment decisions for older adult cancer patients.
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Introduction
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Increasing life expectancy in the United States (US) has contributed to an unprecedented
growth in the population of older Americans. By the year 2030, all baby boomers will be
older than 65 and the US Census Bureau’s 2017 National Population Projections estimate
that older adults will outnumber children by 2035 (1). As individuals in the US live longer,
quality of life (QoL) among older individuals warrants increased attention. Older adults face
declines in physical functioning, including unintentional weight loss, exhaustion, weakness
and decreased physical activity as a product of age (2). Cognitive decline (3,4) and mental
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health concerns, including depression (5,6) and anxiety (6) may also impact quality of life
among older adults. These physical and cognitive declines often limit the activities of daily
living (ADLs) of older individuals, including getting dressed or getting out of bed, further
impacting quality of life (7–10). Some research, however, indicates that older adults have
differing trajectories and that declines in mental health and QoL are not necessarily
synonymous with aging. For example, socioemotional selectivity theory posits that older
adults are more likely to place increasing value on the achievement of emotionally
meaningful goals as compared to younger adults and that this assists with emotion
regulation, potentially leading to better QoL (11). It is unclear, however, how these potential
pockets of resilience for older adults are impacted when faced with a life-threatening illness,
such as cancer.

Author Manuscript
Author Manuscript

Age-related decreases in QoL, including both mental health, physical distress and difficulties
later in life are often compounded by other comorbid conditions, including cancer (12,13).
As a disease primarily of older adults, it is projected that the aging of the US population will
contribute to a 67% increase in the incidence of cancer among older adults versus 11% for
younger adults (14). In general, a diagnosis of cancer is associated with higher rates of
distress even as compared to diagnoses of non-neoplastic diseases with worse prognoses
(15). Further, the rate of depression in cancer patients is significantly higher than in the
general population and is associated with higher mortality rates, with one meta-analysis
conferring up to a 39% increased mortality rate (16–20). Older patients face unique
challenges following a cancer diagnosis given pre-diagnostic poorer quality of life. Older
adult cancer patients are at an increased risk of psychiatric disorders including depression
and anxiety (16,21–24). Risk of suicide may also increase in certain subpopulations of older
adults following a cancer diagnosis (25,26). In addition, an estimated 80% of older cancer
patients experience pain (27) and up to 70% experience fatigue (28) due to their disease.
Measures of patient-reported QoL among older adult cancer patients may provide important
information that could impact treatment preferences and decision making (28). QoL
measures have also been established as significant prognostic indicators of survival
(18,19,29–31).

Author Manuscript

While the increased risk of physical and cognitive impairment in older age and the impacts
of a cancer diagnosis on QoL in older adults are well documented, there is a paucity of
research examining changes in QoL among older individuals before and after a cancer
diagnosis. A systematic review of unmet needs of newly diagnosed cancer patients
undergoing active treatment found that a significant portion of older cancer patients reported
unmet psychological, informational and physical needs (32). As the number of Americans
diagnosed with cancer grows, the US health system and individual providers’ ability to
address QoL among older cancer patients will play a vital role in the well-being and
survivorship of older cancer patients. As such, this study sought to examine changes in QoL
outcomes before and after a new cancer diagnosis among community dwelling adults 65
years and older, using a longitudinal data set of a nationally representative sample of
Medicare beneficiaries. We expect that physical and mental health components of QoL will
decrease after a cancer diagnosis.

Cancer Invest. Author manuscript; available in PMC 2019 September 23.

Schwartz et al.

Page 3

Author Manuscript

Materials and methods
Study design and sample
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This study used annual survey data collected from the National Health and Aging Trend
Study (NHATS), linked to Medicare claims. NHATS is a longitudinal, population-based
survey of late life disability trends and trajectories, drawn from a random sample of
Medicare beneficiaries as of 30 September 2010 who were at least 65 years of age and living
in the contiguous US, with an oversampling of those over age 90 years and non-Hispanic
blacks. The enrollment file represents 96% of all older adults in the United States.
Enrollment interviews were completed between May and November 2011 (33,34). Annual
follow up interviews were completed through 2016. In-person interviews collect detailed
self-reported information on participants’ physical capacity, function, chronic health
conditions, and socio-economic status. Physical and cognitive performance batteries are also
conducted. For the current study, we used the NHATS cohort enrolled in 2011 (with surveys
from 2011 to 2016), and their corresponding Medicare claims from the inpatient, outpatient,
and national claims history (NCH) files from 2009 to 2016. NHATS was conducted via
Johns Hopkins School of Public Health with approval from the Institutional Review Board
(JHSPH IRB # 00002083). All subjects provided written informed consent. The present
study was conducted with approval from The Icahn School of Medicine at Mount Sinai
Review Board for Health Sciences Research.
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Of the 8245 participants enrolled in NHATS in 2011 (71% response rate), we included only
community dwellers (i.e. not in a nursing home facility) at the time of enrollment who
completed enrollment interviews (n=7608). Participants were excluded if they did not have
continuous Part A and B Medicare coverage, or had HMO coverage in the 12 months prior
to their enrollment in NHATS (n=2827), if they had breast, colorectal, lung, or prostate
cancer diagnoses in their Medicare claims within 1 year prior to their enrollment interview
(n=607), or a prior self-reported history of cancer in their enrollment interview (n=306), as
these would indicate prevalent cancers. Self-reported history of cancer was identified if
participants answered “yes” to the question “Please tell me if a doctor ever told you that you
had cancer”, and “yes” to the subsequent question about specific cancer types as “breast”,
“prostate” or “colon”. Since NHATS does not ask specifically about a history of lung cancer,
participants who report an “other” cancer type at their enrollment interview were also
excluded, as these could have included lung cancer. For participants without a history of
cancer (n=3868), the Medicare fee for service (FFS) inpatient, outpatient, and NCH files
were queried from the time of enrollment in NHATS through the end of 2016. Participants
who had at least one ICD-9 code (until October 2015) or ICD-10 (from October 2015
onward) for breast, colorectal, lung, or prostate cancer in that time frame (see Supplemental
Table 1 for list of ICD-9 and ICD-10 codes) were identified as incident cancer cases
(n=297). As ICD-9/ICD-10 codes are more detailed than the cancer questions in the NHATS
survey, we were able to differentiate between each of the 4 major types of cancer for
analysis. The date of the first appearance of a diagnosis code was used as the date of
diagnosis and to categorize the type of cancer. The NHATS interview that most closely
preceded the incident cancer diagnosis was designated the pre-cancer interview, and the
nearest interview after the diagnosis was designated the post-cancer-interview. Participants
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who self-reported a new cancer at or before their pre-cancer interview (prior to the diagnosis
date based on claims) were excluded (n=23). Participants with a pre-cancer interview and a
post-cancer interview were included in the analysis, resulting in an analytic sample of 136
subjects (Figure 1). For a post-hoc analysis comparing the change in QoL indicators over
time between our cancer group and a non-cancer group, we queried the group of NHATS
participants with no history of cancer at their enrollment interview (n=3868), and who were
not recorded as developing cancer. From these participants, we selected a sample who were
enrolled in NHATS in 2011 and had a second interview in 2012 (n=2794) as our non-cancer
comparison group.
Measures

Author Manuscript

Quality of life-related outcome measures were assessed at the time of the pre-cancer
diagnosis interview and of the post-cancer diagnosis interview, in order to evaluate the
change over time. While NHATS does not include standardized measures of health-related
QoL (e.g., SF-12), we assessed five indicators that constitute overall QoL including mental
health (i.e., anxiety and depression symptoms), self-reported physical health, pain, and
functional limitations. These indicators directly map on to five of the SF-12 subscales,
substantiating their use as QoL indicators for the current study.
Mental health
Participants were categorized as having probable depression if they scored ≥3 on the PHQ-2
scale (range: 0–6) (35) and as having probable anxiety if they scored ≥3 on the GAD-2 scale
(range: 0–6), indicating depressive and/or anxiety symptoms within the last month (36).
Physical health

Author Manuscript

Participants were asked to self-report their health as “poor”, “fair”, “good”, “very good”, or
“excellent”, and to indicate whether or not they were bothered by pain in the last month.
Functional limitations
Participants were asked to indicate whether they received help within the last month with
any of the following activities of daily living (ADLs); eating, getting cleaned up, using the
toilet, dressing, walking around inside, and getting out of bed.
Other covariates

Author Manuscript

Older adults’ demographic characteristics included age (at each interview and at diagnosis),
gender, race, education level, marital status, income quartile, and number of chronic
conditions (including heart disease, hypertension, arthritis, osteoporosis, diabetes, lung
disease, stroke, and hip fracture).
Data analysis
Differences in demographics and quality of life were compared across cancer groups at the
time of the pre-cancer interview, using χ2 or Fisher’s exact tests for categorical variables
and Kruskal–Wallis for continuous variables. Univariate changes in each QoL-related item
from pre-cancer interview to post-cancer interview were assessed using McNemar’s test,
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overall and by cancer type. A generalized linear model (GLM), applying a logit link
function, with a generalized estimating equation (GEE) was used to estimate odds ratios
(OR) and 95% confidence intervals (CI) of QoL-related items post diagnosis, compared to
pre-diagnosis to examine the overall effect of time. An additional model including an
interaction between time and cancer type was used to assess differences across cancer types
over time. All analyses were adjusted for cancer type, age at diagnosis, gender, race,
education level, marital status, income, and number of chronic conditions. Sensitivity
analyses were conducted on continuous measures of depression score, anxiety score, and
number of ADLs requiring assistance, as well as for all categories of self-reported health.
Analyses were also conducted without gender as a covariate, as there is strong correlation
between gender and cancer type. Lastly, to account for the complex sampling strategy of
NHATS, a sensitivity analysis with the survey procedures in SAS was performed using
multivariable logistic regression with an indicator variable for survey time as the main
predictor of interest. A post-hoc analysis comparing the overall cancer group to a non-cancer
group with interviews in 2011 and 2012 was done to assess whether the population in
general experienced similar changes in QoL indicators over time, by examining the
interaction between time and cancer status. All analyses were conducted using SAS software
v9.4 (SAS Institute, Cary, NC).

Author Manuscript

Results
Description of sample

Author Manuscript

There were 136 participants with an incident diagnosis of breast, colorectal, lung, or prostate
cancer and both pre-cancer and post-cancer interviews completed in NHATS; 37 with breast
cancer, 26 with colorectal, 26 with lung, and 47 with prostate cancer. The pre-cancer
interview was conducted an average of 7.5 (SE: 0.3) months before diagnosis (range: 0.1–
15.5 months) and the post-cancer interview was conducted an average of 5.5 (SE: 0.3)
months after diagnosis (range: 0.1–15.15 months). On average, the pre- and post-cancer
interviews were 13 (SE: 0.1) months apart (range: 9.0–17.0 months). At the time of their
diagnosis, participants were, on average, 80.0 years old (SE: 0.6), with similar ages across
cancer groups. The sample was approximately evenly split between men and women, and
about 70% non-Hispanic White. Those with prostate cancer were significantly more likely
than those with other cancers to be married (p=.0346), while individuals with breast cancer
were more likely to have attained more than a high school education than those with other
cancer types (p=.0030) (Table 1).
Changes from pre- to post-cancer diagnosis

Author Manuscript

Univariable—At the pre-cancer interview, there was no significant difference in QoLrelated items between cancer types. From pre to post cancer diagnosis, the proportion of
those with probable depression increased from 14.7 to 21.3% (p=.0833); the proportion of
those with self-reported fair/poor health increased from 25.9 to 38.5% (p=.0079) (those
reporting poor health more than doubled from the pre-cancer to post-cancer interview); and
the proportion of those needing help with ≥1 ADL increased from 16.2 to 26.5% (p=.0028).
Among those receiving help with ≥1 ADL, the most common areas of help at the pre-cancer
interview were dressing (>50%), followed by bathing, walking around inside, and eating. At
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the post-cancer interview, there was an increase across all areas of ADLs. Dressing remained
the most common (64%), followed by walking around inside and bathing (53%), getting out
bed (44%), and eating and using the toilet (33%). There was no significant increase in the
percent of people with probable anxiety (10.3 to 13.2%, p=.3938) or those reporting pain
(52.2 to 55.2%, p=.5465). Changes over time overall are shown in Figure 2, and differences
(post-cancer minus pre-cancer) by cancer type are shown in Figure 3.

Author Manuscript
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Multivariable—Among the entire sample, there was a significant increase in the relative
odds of fair/poor self-reported health (ORadj: 2.0, 95% CI: 1.1–3.6), and help with ≥1 ADL
(ORadj: 2.1, 95% CI: 1.3–3.3) at the post-cancer interview, compared to the pre-cancer
interview, while the increase in odds of probable depression was marginally significant
(ORadj: 1.6, 95% CI: 0.9–2.7). There was no significant increase in odds of probable anxiety
or pain in the overall group. When including a time-*cancer type interaction, there was a
significant increase in the relative odds of probable depression and probable anxiety at the
post- compared to the pre-cancer interview for those with colorectal cancer (ORadj: 6.8, 95%
CI: 1.6–29.3; ORadj: 4.0, 95% CI: 1.1–14.8, respectively). There was no significant change
for breast, lung, or prostate cancer for either outcome. The odds of fair/poor self-reported
health at the post cancer interview significantly increased for breast (ORadj: 4.8, 95% CI:
1.3–18.3) with no significant change for colorectal, lung, or prostate cancer. Those with
colorectal cancer also had a significant increase in help with ≥1 ADL, compared to the precancer interview (ORadj: 3.4, 95% CI: 1.2–9.8); while there was no significant change for
the other cancer types. The odds of pain at the post cancer interview, compared to the precancer interview, were similar across all cancer types, with no significant change over time.
Although results are not all significant across the cancer subtypes, we saw a general trend of
worsening quality of life after a cancer diagnosis, with more muted changes in the prostate
cancer subgroup (Figure 4).
Covariates in the model were examined to determine whether they were associated with
QoL-related items. There was a significant inverse association between income and fair/poor
self-reported health (ORadj: 0.2, 95% CI: 0.1–0.5), and help with ≥1 ADL (ORadj: 0.2, 95%
CI: 0.1–0.6) for those with ≥median income, compared to those with < median income.
Increased age at diagnosis was significantly associated with help with ≥1 ADL (ORadj: 1.1,
95% CI: 1.0–1.1). An increased number of chronic conditions was significantly associated
with pain (ORadj:1.6, 95% CI: 1.3–2.1), fair/poor self-reported health (ORadj:2.0, 95% CI:
1.4–2.6), and help with 1 ADL (ORadj: 1.5, 95% CI: 1.1–1.9).

Author Manuscript

Post-hoc analysis—When comparing the non-cancer group (n=2794) to our overall
cancer group, the cancer group was significantly less female. At baseline, there were no
significant differences in age, race, marital status, education, income, number of chronic
conditions, or in any of the QoL-related indicators. In a model adjusted for all covariates, we
found a significant interaction between time and presence of cancer for fair/poor selfreported health (p=.0102) and marginally significant interactions for help with ADLs (p=.
0696) and probable depression (p=.1054). Although not all significant, those without cancer
generally had minimal declines, while those with cancer had more extreme changes over
time (Table 2).
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Sensitivity analyses—In a sensitivity analysis incorporating the complex sampling
design, the associations follow the trends found in the unweighted analysis (see
Supplemental Table 2), particularly for increases in probable depression, fair/poor selfreported health, and help with ≥1 ADL. Additionally, the sensitivity analysis found a
significant increase in probable anxiety at the post cancer interview. As was seen in the
original analyses, there was no significant change on any of the indicators for those with
prostate cancer. When treating depression score, anxiety score, and number of ADLs
requiring assistance as continuous outcomes, there was a significant increase over time in
mean depression score (βadj: 0.29, 95% CI: 0.04–0.55) and mean number of ADLs requiring
assistance (βadj: 0.52, 95% CI: 0.20–0.84), while there was no significant change in anxiety
score (βadj: 0.28, 95% CI: −0.003–0.56). An analysis using all 5 categories of self-reported
health found no significant change over time (ORadj: 1.14, 95% CI: 0.75–1.74)
(Supplemental Table 3). Although significance varied from the original analyses,
particularly for the analyses of cancer subgroups, the general trends remained similar. A
sensitivity analysis excluding gender as a covariate yielded extremely similar results to the
initial analysis (data not shown).

Discussion

Author Manuscript

The present analysis examines the changes in measures associated with QoL from pre- to
post-cancer diagnosis in a sample of community-dwelling older adult participants in
NHATS. Our final analytic sample consisted of 136 participants with a diagnosis of breast,
colorectal, lung or prostate cancer who had completed an interview both pre and post cancer
diagnosis. From pre- to post-diagnosis, when adjusting for demographics, there was a
significant increase in the relative odds of fair/poor self-reported health and needing help
with ADLs and a marginal increase in depression. There was no notable change in probable
anxiety or pain from pre- to post-diagnosis. Although differences across cancer types was
not the main objective of study, we found that baseline QoL-related measures were similar
across cancer types. When examining the change over time, although many results were not
statistically significant, we did see consistent trends of worsening QoL indicators after a
cancer diagnosis, particularly among those with breast, colorectal, and lung cancer. There
was no significant difference in any of the outcomes over time for those with prostate cancer,
and the measured change was consistently less extreme for these patients. This is not
surprising given the potentially better prognosis of prostate cancer compared to the other
cancers that were examined in analyses (37).

Author Manuscript

Overall, QoL indicators among participants were low even prior to diagnosis regardless of
future cancer status. A post-hoc comparison of the NHATS population sample without
cancer and the analytical sample indicated that at the pre-diagnosis interview our sample did
not differ significantly from those without a history of one of the four cancers, who had
interviews at enrollment and 1 year later (n=2794). However, at the post-diagnosis interview,
individuals with cancer were more likely to report fair/poor self-reported health as well as
help with ADLs and probable depression, although the interaction effect was only
statistically significant for the decline in self-reported health for the population with cancer
as compared to those with no cancer history. These results indicate that while older age may
contribute to overall declines in measures associated with QoL, a cancer diagnosis can
Cancer Invest. Author manuscript; available in PMC 2019 September 23.
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accelerate those declines among older adults and suggests that as the population ages,
greater attention to factors associated with QoL among older adults, particularly those with a
cancer diagnosis, is warranted.
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Among the entire sample, there was a significant increase in the relative odds of fair/poor
self-reported health and help with ADLs at the post-cancer interview, compared to the precancer interview. Because cancer is primarily a disease of older adults, its impacts on factors
associated with QoL specifically among older Americans has significant implications for the
treatment of older cancer patients. Our research suggests that a diagnosis of cancer can have
serious negative impacts on the functioning of older cancer patients, which in turn may
impact mortality. Thus, baseline QoL among older adult cancer patients and potential
declines in QoL post-diagnosis should factor into treatment decisions as well as
interventions during and after treatment (16–20,24). For example, it would be important to
assess a patient’s existing social supports in order to best prepare for potential declines in
ADLs and needs regarding overall support in order to attenuate declines in function.

Author Manuscript

There was no notable change in probable anxiety or pain from pre- to post-diagnosis among
the overall sample and the change in depression was marginal, but these changes were
observed in models which included interactions by cancer type. It is possible that cancerspecific factors such as staging and prognosis have greater impact on these specific variables
as opposed to ADLs and overall health (38,39). Also, because timing of treatment is not
factored into analyses, it is possible that post-surgery and/or post-chemotherapy changes in
anxiety, depression and pain would be easier to detect should treatment timing be the point
at which change is assessed. Our group found that pain, for example, increases after surgery
for lung cancer specifically (40,41). Further research should examine the nuances between
changes in QoL factors between pre-diagnosis, diagnosis/pre-treatment, and post-treatment.
Further, tailoring post-treatment psychosocial interventions for particular patients to address
particular needs is important as clinicians start to think about personalized approaches to
care. It is possible that support groups or mind-body interventions will be particularly
beneficial for patients with specific cancer types at specific stages of treatment.

Author Manuscript

Notably, several demographic characteristics were significantly associated with increased
odds of poor QoL-related outcomes post-diagnosis. There was a significant inverse
association between income and fair/poor self-reported health and help with ≥1 ADL. This
relationship could reflect a lack of access to higher-quality cancer care among lower-income
older cancer patients or a lack of access to other resources that may could improve QoL, like
in-home care or assistance. The relationship between socioeconomic status and self-reported
health among older cancer patients is a potential point of intervention and should be
examined in future research. In addition, increased age at diagnosis was significantly
associated with help with ≥1 ADL. This may reflect the fact that increased age contributes to
lower QoL even before a cancer diagnosis which, in turn, could contribute to greater changes
in QoL-related factors post-diagnosis. This points to the need to for providers to pay
particular attention to much older patients’ needs and existing support systems after a cancer
diagnosis is made.
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The findings should be interpreted in the context of the study limitations. Due to eligibility
criteria, our final analytic sample is small in comparison to the larger sampling frame. Due
to this small sample size, we may have lacked sufficient statistical power to capture changes
over time in some of the QoL indicators, particularly among the cancer type subgroups. In
addition, our analysis did not include information in regard to prognosis, staging and
treatment, all data points pertinent to QoL following a cancer diagnosis. Prognosis and
staging information cannot be found in Medicare claims, and inclusion of treatment
information would have necessitated more stringent Medicare coverage requirements, which
would have further limited our sample size. Furthermore, standard treatment differs by stage
and cancer type, so treatment burdens likely would not have been comparable across groups,
Also, bias may have been introduced by limiting to those who had a second interview since
those who had a second interview generally lived longer than those who were identified with
incident cancer, but did not have a follow up interview. Our analysis of differences indicated
that the final analytic sample may have been healthier, had earlier stage cancer and a better
prognosis and were part of demographic groups with higher QoL which could potentially
bias the results to the null in that less change in QoL could be evident. Another limitation to
note is the correlation between gender and cancer type, with prostate and breast each present
in a single gender. We ran our analyses without the inclusion of gender and found very
similar results, but due to sample size constraints, were unable to run analyses stratified by
gender. Given this constraint, it is difficult to fully untangle the effects of gender on QoL.
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This is one of the first studies, to our knowledge, to assess changes in patient-centered
outcomes after a cancer diagnosis in an older adult population. The findings from this study
can be used to help older cancer patients, their families and their providers to make
treatment decisions regarding how to best maximize factors related to better QoL. The
results suggest the importance of the consideration of baseline QoL-related indicators when
making treatment decisions for older adult cancer patients. Furthermore, the results suggest
the potential for interventions to target important QoL-related factors in order to prepare
patients for post-treatment experience and ensure that there are supportive services in place
to buffer/address the potential decreases in physical and mental health and functioning.
Consistent with socioemotional selectivity theory (11), it is possible that maximizing
emotion-related goals, such as increasing social interaction and support, will result in more
positive outcomes even for older adults facing cancer. Finally, particular attention should be
focused on vulnerable populations including low-income and older patients, who may be at a
greater risk for declines in QoL.

Author Manuscript

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.

Selection criteria used to identify eligible NHATS cases.
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Figure 2.

Change in quality of life indicators from pre- to post-cancer diagnosis.
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Figure 3.
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Difference in percent (post- minus pre-cancer diagnosis) of respondents reporting quality of
life indicators, according to cancer type. SRH: Self-Reported Health; ADL: Activity of
Daily Living. Difference is shown to mask small cell sizes at both time points.
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Adjusted odds of poor quality of life indicators post-cancer diagnosis, compared to precancer diagnosis.
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